Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis

Blood (2015) 126 (8): 1009–1016.

https://doi.org/10.1182/blood-2014-12-614743

Published: 2015

Includes: Supplemental data

Journal Articles

Use of Human Immunoglobulins in Secondary Immunodeficiencies Associated with Hematological Malignancy in Real-Life Practice: Which Patients, Which Treatment?

Omar Benbrahim, MD, Bernard Grosbois, MD PhD, Jean-François Viallard, MD PhD, Sylvain Choquet, MD, Bruno Royer, MD, Brigitte Dreyfus, MD, Emmanuel Fleck, MD, Miguel Carreiro, MD, Pierre Clerson, MD, Jean Charles Crave, MD PhD, Jean-christophe Delain, PharmD, Vincent Levy, MD

Blood (2014) 124 (21): 4972.

https://doi.org/10.1182/blood.V124.21.4972.4972

Published: 2014

Journal Articles

Thalidomide in Advanced Mastocytosis. Results from an Open-Label, Multicentric, Phase II Study

Berengere Gruson, Olivier Lortholary, MD, PhD, Danielle Canioni, marie-Olivia Chandesris, Fanny Lanternier, Bernard Grosbois, Sr., MD, Cristina Livideanu, MD, Thierry Lamy, MD, PhD, Henri Sevestre, MD, PhD, Claire Larroche, MD, Aurélie Esparcieux, MD, Guillaume Chaby, MD, Jean Pierre Marolleau, MD, Olivier Hermine, MD, PhD, Gandhi Damaj, MD

Blood (2011) 118 (21): 1754.

https://doi.org/10.1182/blood.V118.21.1754.1754

Published: 2011

Journal Articles

Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial

Blood (2011) 117 (11): 3041–3044.

https://doi.org/10.1182/blood-2010-08-300863

Published: 2011

Journal Articles

Acquired Hemophilia Associated with Smoldering Myeloma: Demonstration That the Monoclonal Gammopathy Acts as the Factor VIII Inhibitor.

Olivier Decaux, Benoit Guillet, Arnaud Millet, Stephen Harding, Arthur R. Bradwell, Bernard Grosbois, Patrick Jego

Blood (2009) 114 (22): 1307.

https://doi.org/10.1182/blood.V114.22.1307.1307

Published: 2009

Journal Articles

Interest of Diffusion Weighted Magnetic Resonance Imaging for the Evaluation of Bone Marrow Infiltration in Multiple Myeloma, Smoldering Myeloma and Monoclonal Gammopathy of Undetermined Significance.

Olivier Decaux, Thierry Josseaume, Eric Brillet, Thierry Lamy, Marc Bernard, Martine Escoffre, Martine Sebillot, Bernard Grosbois, Regis Duvauferrier

Blood (2009) 114 (22): 4874.

https://doi.org/10.1182/blood.V114.22.4874.4874

Published: 2009

Journal Articles

Clinical and Biological Features of Biclonal Gammopathies. Review of 203 Cases

Olivier Decaux, MD, Helene Leroy, Jean-Christophe Ianotto, MD, Annie Ruelland, MD, Lucienne Guenet, MD, Martine Sebillot, MD, Patrick Jego, MD, PhD, Bernard Grosbois, MD, PhD

Blood (2008) 112 (11): 5151.

https://doi.org/10.1182/blood.V112.11.5151.5151

Published: 2008

Journal Articles

A Multicenter Phase I/II Dose Escalation Study of Lenalidomide in Combination with Melphalan and Dexamethasone in Subjects with Newly-Diagnosed Light-Chain (AL)-Amyloidosis.

Philippe Moreau, Arnaud Jaccard, Lotfi Benboubker, MD, Bruno Royer, Valerie Coiteux, MD, Franck Bridoux, Jean-Luc Harousseau, Catherine Traulle, Bernard Grosbois, MD, PhD, Veronique Leblond, May Alakl, Olivier Hermine, Jean-Paul Fermand

Blood (2008) 112 (11): 1732.

https://doi.org/10.1182/blood.V112.11.1732.1732

Published: 2008

Journal Articles

Regular Follow-Up of MGUS Allow Early Detection of Malignant Transformation Before Severe Complications Occur.

Olivier Decaux, MD, Sophie Besnard, Antoinette Perlat, Md, Claire Cazalets, Md, Berengere Cador, Md, Martine Sebillot, Md, Patrick Jego, Md, phd, Bernard Grosbois, Md, phd

Blood (2007) 110 (11): 4774.

https://doi.org/10.1182/blood.V110.11.4774.4774

Published: 2007

Journal Articles

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Blood (2007) 109 (8): 3489–3495.

https://doi.org/10.1182/blood-2006-08-040410

Published: 2007

Includes: Supplemental data

Journal Articles

Monoclonal Gammopathy (MG) Associated with Gaucher Disease (GD). Report of 16 Cases from the French Observatoire on Gaucher Disease (FROG Study).

Bernard Grosbois, MD, Jean Leone, MD, Fabrice Camou, MD, Florence Dalbies, MD, Jean Robert Harle, MD, Thierry Lamy, MD, Luminita Luca, MD, Christophe Plane, MD, Jean Pierre Robin, MD, Christian Rose, MD, Christine deRoux-Serratrice, MD, Eric Solary, MD, Jean Marie Steiger, MD

Blood (2006) 108 (11): 5004.

https://doi.org/10.1182/blood.V108.11.5004.5004

Published: 2006

Journal Articles

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Blood (2006) 107 (4): 1292–1298.

https://doi.org/10.1182/blood-2005-04-1588

Published: 2006

Journal Articles

Impaired Mobilization of Peripheral Blood Stem Cell (PBSC) after Fludarabine Treatment: Comparison of Results Using 3 Different Procedures.

Philippe Genet, MD, Philippe Travade, MD, Bruno Cazin, MD, Stephane Lepretre, MD, Marine Divine, MD, Claude Martin, MD, Veronique Leblond, MD, Eric Van Den Neste, MD, Frederic Maloisel, MD, Mauricette Michallet, MD, Houchingue Eghbali, MD, Christian Berthou, MD, Alain Delmer, MD, Bernard Grosbois, MD, Pierre Feugier, MD, Michel Leporrier, MD, Laurent Sutton, MD, Olivier Tournilhac, MD

Blood (2005) 106 (11): 1978.

https://doi.org/10.1182/blood.V106.11.1978.1978

Published: 2005

Journal Articles

Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia

Olivier Tournilhac, Bruno Cazin, Stéphane Leprètre, Marine Diviné, Karim Maloum, Alain Delmer, Bernard Grosbois, Pierre Feugier, Frederic Maloisel, Florence Villard, Bruno Villemagne, Dominique Bastit, Karim Belhadj, Nabi Azar, Mauricette Michallet, Geraud Manhès, Philippe Travade

Blood (2004) 103 (1): 363–365.

https://doi.org/10.1182/blood-2003-05-1449

Published: 2004

Journal Articles

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

Hervé Avet-Loiseau, Thierry Facon, Bernard Grosbois, Florence Magrangeas, Marie-José Rapp, Jean-Luc Harousseau, Stéphane Minvielle, Régis Bataille

Blood (2002) 99 (6): 2185–2191.

https://doi.org/10.1182/blood.V99.6.2185

Published: 2002

Journal Articles

Comparison of 200 mg/m 2 melphalan and 8 Gy total body irradiation plus 140 mg/m 2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial

Blood (2002) 99 (3): 731–735.

https://doi.org/10.1182/blood.V99.3.731

Published: 2002

Journal Articles

Prognostic factors in Waldenström macroglobulinemia: a report on 232 patients with the description of a new scoring system and its validation on 253 other patients

Pierre Morel, Mathieu Monconduit, Dominique Jacomy, Pascal Lenain, Bernard Grosbois, Christine Bateli, Thierry Facon, Isabelle Dervite, Francis Bauters, Albert Najman, Aimery de Gramont, Eric Wattel

Blood (2000) 96 (3): 852–858.

https://doi.org/10.1182/blood.V96.3.852

Published: 2000

Journal Articles

Monosomy 13 Is Associated With the Transition of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Hervé Avet-Loiseau, Jian-Yong Li, Nadine Morineau, Thierry Facon, Christophe Brigaudeau, Jean-Luc Harousseau, Bernard Grosbois, Régis Bataille

Blood (1999) 94 (8): 2583–2589.

https://doi.org/10.1182/blood.V94.8.2583.420a05_2583_2589

Published: 1999

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria: Efficacy of Prolonged Treatment With Granulocyte Colony-Stimulating Factor

Patrick Jégo, Anne Le Strat, Laurence Girard, Martine Sébillot, Bernard Grosbois, Robert Le Blay, Bernard Drénou

Blood (1997) 90 (7): 2841–2842.

https://doi.org/10.1182/blood.V90.7.2841

Published: 1997

NARROW

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis

Use of Human Immunoglobulins in Secondary Immunodeficiencies Associated with Hematological Malignancy in Real-Life Practice: Which Patients, Which Treatment?

Thalidomide in Advanced Mastocytosis. Results from an Open-Label, Multicentric, Phase II Study

Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial

Acquired Hemophilia Associated with Smoldering Myeloma: Demonstration That the Monoclonal Gammopathy Acts as the Factor VIII Inhibitor.

Interest of Diffusion Weighted Magnetic Resonance Imaging for the Evaluation of Bone Marrow Infiltration in Multiple Myeloma, Smoldering Myeloma and Monoclonal Gammopathy of Undetermined Significance.

Clinical and Biological Features of Biclonal Gammopathies. Review of 203 Cases

A Multicenter Phase I/II Dose Escalation Study of Lenalidomide in Combination with Melphalan and Dexamethasone in Subjects with Newly-Diagnosed Light-Chain (AL)-Amyloidosis.

Regular Follow-Up of MGUS Allow Early Detection of Malignant Transformation Before Severe Complications Occur.

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Monoclonal Gammopathy (MG) Associated with Gaucher Disease (GD). Report of 16 Cases from the French Observatoire on Gaucher Disease (FROG Study).

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Impaired Mobilization of Peripheral Blood Stem Cell (PBSC) after Fludarabine Treatment: Comparison of Results Using 3 Different Procedures.

Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

Comparison of 200 mg/m 2 melphalan and 8 Gy total body irradiation plus 140 mg/m 2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial

Prognostic factors in Waldenström macroglobulinemia: a report on 232 patients with the description of a new scoring system and its validation on 253 other patients

Monosomy 13 Is Associated With the Transition of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Paroxysmal Nocturnal Hemoglobinuria: Efficacy of Prolonged Treatment With Granulocyte Colony-Stimulating Factor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only